Open-Label Extension (OLE) Study to Assess Safety, Efficacy, and Tolerability of Lorundrostat in Subjects With Hypertension
Trial details
- Registry ID
- NCT05968430
- Phase
- Phase 3
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Open-Label Extension (OLE) Study to Assess Safety, Efficacy, and Tolerability of Lorundrostat in Subjects With HypertensionNCT05968430 | MLYS | Phase 3 | Active not recruiting | 2025-12-30Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |